Cognition Café

Do not miss out on the opportunity to listen to four leading international experts discuss and share clinical insights on cognitive function in subjects at risk for or suffering from

bipolar disorder or schizophrenia.

REGISTER

outline

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey.

This highly interactive program will combine pre-recorded and live elements and be based on a series of challenging questions pertaining to cognition in bipolar disorder and schizophrenia. Throughout the first part of the symposium (pre-recorded), the audience will be asked to answer polling questions through the online platform to ensure interactivity of the session. During the live session, participants will be encouraged to ask questions via the chat and the subject-matter experts will be able to answer these live.

objectives

After taking part in this symposium, participants will be better able to:

- Describe the magnitude and trajectory of cognitive impairments in bipolar disorder (BD) and schizophrenia and the impact of these impairments on clinical outcomes;

- Evaluate the effects of psychotropic medications on neurocognitive functioning in patients with BD and schizophrenia;

- Implement cognitive and functional remediation strategies as well as pharmacologic interventions for the prevention and treatment of cognitive dysfunction in these patients.

CO-CHAIR:

Prof LAKSHIMI YATHAM

MBBS, FRCPC, MRCPsych, MBA (Exec)

Professor and Head of Psychiatry
University of British Columbia

President, World Federation of Societies of Biological Psychiatry

Vancouver, Canada

CO-CHAIR:

Prof EDUARD VIETA

MD, PhD

Professor of Psychiatry at the University of Barcelona and Chair of the Department of Psychiatry and Psychology at the Hospital Clinic
Scientific Director of the Biomedical Research Center Network of Mental Health

Barcelona, Spain

EXPERT PANELIST:

Prof ALLAN YOUNG

MB.ChB, MPhil, PhD, FRCPsych, FRCPC, FRSB Professor of Psychiatry
Chair of Mood Disorders
Director of the Centre for Affective Disorders

Vice Dean, Academic Psychiatry
Institute of Psychiatry, Psychology & Neuroscience at King’s College London

London, UK

EXPERT PANELIST:

Prof PHILIP HARVEY

PhD

Leonard M. Miller Professor of Psychiatry and Behavorial Sciences,
Director of the Division of Psychology
University of Miami, Miller School of Medicine

Miami, USA

An application has been made to the UEMS EACCME® for CME accreditation of this event.

agenda

7:00 - 7:10 PM

Welcome & Introduction

Professor Yatham & Professor Vieta

7:10 - 7:40 PM

Q&A session on Bipolar Disorder and Schizophrenia

Professor Yatham, Professor Vieta, Professor Young, Professor Harvey

A series of questions on what clinicians need to know with respect to cognition in bipolar disorder and schizophrenia will be asked from Prof. Young and Prof. Harvey, the subject-matter experts.

7:40 - 8:20 PM

Q&A session with Subject-Matter Experts and Participants

Professor Yatham, Professor Vieta, Professor Young, Professor Harvey

8:20 - 8:30 PM

Closing Remarks and Evaluations

Professor Yatham & Professor Vieta

SUPPORTERS / SPONSORS:

This symposium was made possible through an unrestricted educational grant from Sumitomo Dainippon Pharma Co., Ltd.

We are looking forward to welcoming you soon!

REGISTER

The Final Countdown!

Time left for the event days hours minutes seconds

The countdown doesn't work if the event start date is set to TBD

for technical support during the Symposium, please email: support@tecnika.ca

Supporters / Sponsors:

This symposium was made possible through an unrestricted educational grant from Sumitomo Dainippon Pharma Co., Ltd.

Sponsors Block #1

cognition café

OUTLINE

objectives

FACULTY

register

sponsor

AGENDA

Do not miss out on the opportunity to listen to four leading international experts discuss and share clinical insights on cognitive function in subjects at risk for or suffering from bipolar disorder or schizophrenia.

Monday, June 28, 2021

_{^{7pm to 8:30pm CET (Central European Time)}}

Do not miss out on the opportunity to listen to four leading international experts discuss and share clinical insights on cognitive function in subjects at risk for or suffering from bipolar disorder or schizophrenia.

REGISTER

Clear your calendar - It's going down! Splash Blocks kicks off on April 21st, and you're invited to take part in the festivities. Splash HQ (122 W 26th St) is our meeting spot for a night of fun and excitement. Come one, come all, bring a guest, and hang loose. This is going to be epic!

An application has been made to the UEMS EACCME® for CME accreditation of this event.

The Final Countdown!

Time left for the event days hours minutes seconds

The countdown doesn't work if the event start date is set to TBD

Time left for the event days hours minutes seconds

The countdown doesn't work if the event start date is set to TBD

You are invited to attend a

VIRTUAL SYMPOSIUM

_{Monday, June 28 at 7:00pm CET}
_{^{Central European Time}}

Do not miss out on the opportunity to listen to four leading international experts discuss and share clinical insights on cognitive function in subjects at risk for or suffering from bipolar disorder or schizophrenia.

REGISTER

OUTLINE

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey.

This highly interactive program will combine pre-recorded and live elements and be based on a series of challenging questions pertaining to cognition in bipolar disorder and schizophrenia. Throughout the first part of the symposium (pre-recorded), the audience will be asked to answer polling questions through the online platform to ensure interactivity of the session. During the live session, participants will be encouraged to ask questions via the chat and the subject-matter experts will be able to answer these live.

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey

objectives

AFTER TAKING PART IN THIS SYMPOSIUM, PARTICIPANTS WILL BE BETTER ABLE TO:

- Describe the magnitude and trajectory of cognitive impairments in bipolar disorder (BD) and schizophrenia and the impact of these impairments on clinical outcomes;

- Evaluate the effects of psychotropic medications on neurocognitive functioning in patients with BD and schizophrenia;

- Implement cognitive and functional remediation strategies as well as pharmacologic interventions for the prevention and treatment of cognitive dysfunction in these patients.

OBJECTIVES

After taking part in this symposium, participants will be better able to:

- Describe the magnitude and trajectory of cognitive impairments in bipolar disorder (BD) and schizophrenia and the impact of these impairments on clinical outcomes;

- Evaluate the effects of psychotropic medications on neurocognitive functioning in patients with BD and schizophrenia;

- Implement cognitive and functional remediation strategies as well as pharmacologic interventions for the prevention and treatment of cognitive dysfunction in these patients.

Cognition Café

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey.

This highly interactive program will combine pre-recorded and live elements and be based on a series of challenging questions pertaining to cognition in bipolar disorder and schizophrenia. Throughout the first part of the symposium (pre-recorded), the audience will be asked to answer polling questions through the online platform to ensure interactivity of the session. During the live session, participants will be encouraged to ask questions via the chat and the subject-matter experts will be able to answer these live.

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey

Monday, June 28 at 7:00pm CET

Central European Time

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey.

This highly interactive program will combine pre-recorded and live elements and be based on a series of challenging questions pertaining to cognition in bipolar disorder and schizophrenia. Throughout the first part of the symposium (pre-recorded), the audience will be asked to answer polling questions through the online platform to ensure interactivity of the session. During the live session, participants will be encouraged to ask questions via the chat and the subject-matter experts will be able to answer these live.

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey

RSVP

In-Person Details

The live event includes programming that includes safe and socially-distanced networking, a plenary session, panel discussion, and an interactive forum. All health and safety measures can be found below or by clicking the "Health" link above.

Tuesday

,

August

31

–

Wednesday

,

September

1

,

2021

Starting at

9:00am

EDT

Ending at

6:00pm

EDT

agenda

7:00 - 7:10 PM

Welcome & Introduction – pre-recorded

Professor Yatham & Professor Vieta

The chairs / moderators will present the faculty, the objectives and the ACUMEN program:
o Introduction of speakers, including their conflict of interest disclosures

o Presentation of symposium objectives

o Presentation of the ACUMEN program

(14 e-learning modules developed in 2018 for health-care professionals by WFSBP):

content and key take-aways

7:10 - 7:25 PM

Bipolar Disorder – pre-recorded

Professor Yatham, Professor Vieta, Professor Young

o A series of questions on what clinicians need to know with respect to cognition in bipolar disorder will be asked from Prof. Young, the subject-matter expert. The following areas will be covered:

- Cognitive Impairment in Bipolar Disorder

- Cognitive Screening / Assessment in BD

- Neurobiology of Cognitive Impairments in BD

- Cognitive Effects of Psychotropic Medications

- Treatment and Management of Cognitive Impairment in BD

o Participants will be asked polling questions throughout the session through the online platform to ensure interactivity of the session

7:25 PM - 7:40 PM

Schizophrenia – pre-recorded

Professor Yatham, Professor Vieta, Professor Young

o A series of questions on what clinicians need to know with respect to cognition in schizophrenia will be asked from Prof Harvey, the subject-matter expert:

- Cognitive Impairment in Schizophrenia

- Cognitive Effects of Psychotropic Medication

- Pharmacological Treatment of Cognitive Impairment in Schizophrenia

- Cognitive and Functional Remediation of Schizophrenia

o Participants will be asked polling questions throughout the session through the online platform to ensure interactivity of the session

7:40 - 8:20 PM

Q&A session: Live discussion with the subject-matter experts

Professor Yatham, Professor Vieta, Professor Young, Professor Harvey

o All speakers join the platform ‘live’

o The panel will answer questions pertaining to cognition in bipolar disorder and schizophrenia that will be typed in the chat box by participants

o A few pre-selected questions will be created and typed in the chat box to get the Q&A section started

8:20 - 8:30 PM

Closing Remarks and Evaluations

Professor Yatham & Professor Vieta

o Final words from the moderators

o Two-three take-away messages

o Closing statements by the moderators

o Evaluation form link posted in the chat

6:45 - 7:30 PM

Sip, Snack and Chat

Drop your business card in the bowl on your way out for a chance to win free lunch for your team.

Schedule Block #5

Clear your calendar - It's going down! Schedule Blocks kicks off on May 20th, and you're invited to take part in the festivities. Splash HQ (122 W 26th St) is our meeting spot for a night of fun and excitement. Come one, come all, bring a guest, and hang loose. This is going to be epic!

Clear your calendar - It's going down! Schedule Blocks kicks off on May 20th, and you're invited to take part in the festivities. Splash HQ (122 W 26th St) is our meeting spot for a night of fun and excitement. Come one, come all, bring a guest, and hang loose.

Day of the Event

Mar. 25th 8:00am

Clear your calendar - It's going down! Schedule Blocks kicks off on May 20th, and you're invited to take part in the festivities.

Mar. 25th 9:00am

Clear your calendar - It's going down! Schedule Blocks kicks off on May 20th, and you're invited to take part in the festivities.

Virtual Details

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey

This highly interactive program will combine pre-recorded and live elements and be based on a series of challenging questions pertaining to cognition in bipolar disorder and schizophrenia. Throughout the first part of the symposium (pre-recorded), the audience will be asked to answer polling questions through the online platform to ensure interactivity of the session. During the live session, participants will be encouraged to ask questions via the chat and the subject-matter experts will be able to answer these live.

Important topics on cognition in bipolar disorder, including cognitive impairment, cognitive screening, neurobiology of cognitive impairments, cognitive effects of psychotropic medications as well as treatment and management of cognitive impairment will be featured in the symposium and addressed by Prof. Young. Furthermore, cognitive impairment in schizophrenia, cognitive effects of psychotropic medication, pharmacological treatment of cognitive impairment in schizophrenia as well as cognitive and functional remediation of schizophrenia will be discussed by Prof. Harvey.

OBJECTIVES

After taking part in this symposium,

participants will be better able to:

Socially-distanced Networking

- Describe the magnitude and trajectory of cognitive impairments in bipolar disorder (BD) and schizophrenia and the impact of these impairments on clinical outcomes;

Plenary: a Keynote from Jane Parsnip

- Evaluate the effects of psychotropic medications on neurocognitive functioning in patients with BD and schizophrenia;

2pm

Break

- Implement cognitive and functional remediation strategies as well as pharmacologic interventions for the prevention and treatment of cognitive dysfunction in these patients.

2:15pm

Panel Discussion

Our speakers Phil July and Veronica Valerie will engage in a panel discussion with Jane Parsnip moderating.

3pm

Interactive Forum

To close out the event, engage in an interactive forum of open discussion with your fellow guests.

OBJECTIVES

_{^{After taking part in this symposium,}}

_{^{participants will be better able to:}}

- Evaluate the effects of psychotropic medications on neurocognitive functioning in patients with BD and schizophrenia;

-Implement cognitive and functional remediation strategies as well as pharmacologic interventions for the prevention and treatment of cognitive dysfunction in these patients.

Virtual Agenda

1pm

Socially-distanced Networking

Check in on the Virtual Event Page via your personalized link in your confirmation email and get sorted into a networking breakout room.

1:30pm

Plenary: a Keynote from Jane Parsnip

Enjoy a keynote from Jane Parsnip who will present on the future of hybrid events back to the main session. You'll be redirected automatically.

2pm

Break

Take a break from the event. We'll have some opportunities to continue to network using the apps Kumospace and Kahoot. Remain signed in to the main session on the Virtual Event Page, or sign out following the instructions in the Virtual Details section above.

2:15pm

Panel Discussion

Our speakers Phil July and Veronica Valerie will engage in a panel discussion with Jane Parsnip moderating, back in the main session.

3pm

Interactive Forum

To close out the event, engage in an interactive forum of open discussion with your fellow guests. Participate in this session by using the "raise hand" feature on the Virtual Event page.

Speakers

Jane Parsnip

Graphic Designer

Jane Parsnip has eight years of experience as a graphic designer.

Phil July

Photographer

Phil July has eight years of experience as a photographer.

Veronica Valerie

Graphic Designer

Veronica Valerie has eight years of experience as a graphic designer.

Video

In-Person Health and Safety Information

We are taking every possible health precaution to keep you safe should you join us for the live events. We want to take every measure to protect against emergent strains or a failure to develop immune responses to Covid-19.

Upon arrival, we will take your temperature, and you will fill out a contactless health declaration and check-in. We will continue to practice social distancing and mask-wearing in the common space.

If your health status changes, you can always modify your RSVP via your confirmation or reminder emails.

OPTIONAL BULLETED LIST:

Temperature checks upon arrival
Contactless health declaration
Continue practicing social distancing, mask-wearing in common space, and using common sense
In the end, guests attend at their own risk

In-Person Venue

RSVP

Virtual Venue

Join us on the Splash Virtual Event Page for an interactive event on Zoom. We will use Zoom Breakouts for the networking portion of the event, as well as the Kahoot app for participatory activities. During the Interactive Forum, use the "raise hand" feature to take part.

After registering, you will receive a confirmation email with a link that is unique to you and which cannot be shared or re-used. We will also provide you with the ability to modify your RSVP in the future, and will send you a reminder email as the event approaches.